百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

未开盘 11-26 16:08:11

5.900

+0.010

+0.17%

最高6.030	最低5.810	成交量13.55万
今开5.900	昨收5.890	日振幅3.74%
总市值23.56亿	流通市值6.55亿	总股本3.99亿
成交额80.41万	换手率0.12%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":5.9,"timestamp":1732608491029,"preClose":5.89,"halted":0,"volume":135500,"delay":0,"floatShares":111000000,"shares":399398420,"eps":-1.0306226,"marketStatus":"未开盘","marketStatusCode":0,"change":0.01,"latestTime":"11-26 16:08:11","open":5.9,"high":6.03,"low":5.81,"amount":804130,"amplitude":0.037351,"askPrice":5.94,"askSize":2000,"bidPrice":5.87,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.6562661539634977,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732671000000},"adr":0,"listingDate":1661961600000,"adjPreClose":5.89,"openAndCloseTimeList":[[1732584600000,1732593600000],[1732597200000,1732608000000]],"volumeRatio":0.9977908677492892,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315/tweets","defaultTab":"tweets","newsList":[{"id":"2486773519","title":"百奥赛图-B盘中异动 下午盘股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486773519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486773519?lang=zh_cn&edition=full","pubTime":"2024-11-25 14:35","pubTimestamp":1732516547,"startTime":"0","endTime":"0","summary":"2024年11月25日下午盘14时35分，百奥赛图-B股票出现波动，股价大幅拉升5.47%。截至发稿，该股报5.980港元/股，成交量7.2万股，换手率0.06%，振幅4.23%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.43%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112514354798e4458b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112514354798e4458b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2486472667","title":"投资者速看！“第九届智通财经资本市场年会”活动报名中！","url":"https://stock-news.laohu8.com/highlight/detail?id=2486472667","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486472667?lang=zh_cn&edition=full","pubTime":"2024-11-25 10:32","pubTimestamp":1732501959,"startTime":"0","endTime":"0","summary":"“立根中国资产·破岩2025”第九届智通财经资本市场年会，将于2024年12月11-13日在深圳、香港两地隆重举行！盛会设置四大专题版块：“第九届智通财经资本市场年会暨上市公司颁奖典礼”、“智通财经新春策略会”、第二届中资海外基金高峰论坛暨新智奖颁奖典礼、金中环论坛（香港）。作为大会主旋律之一的 “智通财经新春策略会”将在12月11日下午至12日（全天）举行，届时将有100+港、美、A股上市公司集中正向路演。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09877","06919","00826","09919","01755","02315","00302","02498","00363","03700","06609","02411","02256","01783","06633","02362","03306","09616","02420","03709","02273","03800","03877","06608","01907","01651","02190","01313","02105","00086","02598","01083","09959","00855","06821","06830","00666","01558","00857","02268","02171","00992","02858","01450","06098","00861","09911","00552","01672","01600"],"gpt_icon":0},{"id":"2485407792","title":"百奥赛图-B盘中异动 下午盘急速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485407792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485407792?lang=zh_cn&edition=full","pubTime":"2024-11-22 13:06","pubTimestamp":1732252006,"startTime":"0","endTime":"0","summary":"2024年11月22日下午盘13时06分，百奥赛图-B股票出现波动，股价快速下挫5.33%。截至发稿，该股报5.680港元/股，成交量7.15万股，换手率0.06%，振幅3.17%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。百奥赛图-B股票所在的生物技术行业中，整体跌幅为1.20%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122130646971a806e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122130646971a806e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2485102205","title":"百奥赛图-B盘中异动 急速拉升6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485102205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485102205?lang=zh_cn&edition=full","pubTime":"2024-11-21 09:30","pubTimestamp":1732152607,"startTime":"0","endTime":"0","summary":"2024年11月21日早盘09时30分，百奥赛图-B股票出现异动，股价急速上涨6.50%。截至发稿，该股报6.390港元/股，成交量500股，换手率0.00%，振幅0.00%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，百奥赛图-B、科伦博泰生物-B、乐普生物-B涨幅较大，振幅较大的相关个股有宜明昂科-B、康希诺生物、百济神州，振幅分别为1.90%、1.82%、1.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112109300798e43d47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112109300798e43d47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2484955750","title":"百奥赛图-B盘中异动 大幅上涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484955750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484955750?lang=zh_cn&edition=full","pubTime":"2024-11-19 10:03","pubTimestamp":1731981797,"startTime":"0","endTime":"0","summary":"2024年11月19日早盘10时03分，百奥赛图-B股票出现异动，股价急速上涨6.67%。截至发稿，该股报6.400港元/股，成交量2.45万股，换手率0.02%，振幅9.00%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.09%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119100317a2446319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119100317a2446319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2484660720","title":"百奥赛图－Ｂ(02315)股价显著波动14.59%，现价港币$5.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2484660720","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484660720?lang=zh_cn&edition=full","pubTime":"2024-11-18 10:34","pubTimestamp":1731897240,"startTime":"0","endTime":"0","summary":"[异动股]百奥赛图－Ｂ(02315) 股价在上午10:34出现显著波动14.59%，现股价为港币$5.91，比前收市价下跌3.115%7.213%。至目前为止，今日最高价为$6.55，而最低价为$5.66。总成交量为1.3万股，总成交金额为港币$7.85万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625308_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625308_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC24111836/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2483459623","title":"百奥赛图-B(02315)上涨7.32%，报6.01元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483459623","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483459623?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:59","pubTimestamp":1731657589,"startTime":"0","endTime":"0","summary":"11月15日，百奥赛图-B(02315)盘中上涨7.32%，截至15:59，报6.01元/股，成交103.69万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/15155945336421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2483666364","title":"百奥赛图-B盘中异动 股价大涨6.07%报5.940港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483666364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483666364?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:36","pubTimestamp":1731634591,"startTime":"0","endTime":"0","summary":"2024年11月15日早盘09时36分，百奥赛图-B股票出现异动，股价快速拉升6.07%。截至发稿，该股报5.940港元/股，成交量3500股，换手率0.00%，振幅5.89%。资金方面，该股资金流入1.1935万港元，流出3050港元。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，迈博药业-B、百奥赛图-B、宜明昂科-B涨幅较大，振幅较大的相关个股有晶泰科技、荃信生物-B、百奥赛图-B，振幅分别为9.88%、6.15%、5.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093631abc2ab93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093631abc2ab93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2482573534","title":"百奥赛图(02315.HK)获IDEAYA提名首创潜力B7H3/PTK7为开发候选药","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573534","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573534?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:01","pubTimestamp":1731337260,"startTime":"0","endTime":"0","summary":"百奥赛图－Ｂ(02315.HK) 公布，IDEAYA Biosciences (IDYA.US)  已行使选择权，获得公司具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性抗体偶联药物BCG034的全球独家授权，并提名该项目为开发候选药物。根据协议，公司将获得首付款和选择权行使费、额外的开发和监管里程碑付款、商业化里程碑付款以及净销售额分成，总额达4.065亿美元，其中包括最多1亿美元的临床开发和监管里程碑付款。(de/d)(港股报价延迟最少十五分钟。) (美股为即时串流报价； OTC市场股票除外，资料延迟最少15分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221007162300628_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221007162300628_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395749/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2482920726","title":"百奥赛图-B获4.1亿美元授权 IDE034或成新抗癌药","url":"https://stock-news.laohu8.com/highlight/detail?id=2482920726","media":"财中社","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482920726?lang=zh_cn&edition=full","pubTime":"2024-11-11 19:28","pubTimestamp":1731324480,"startTime":"0","endTime":"0","summary":"财中社11月11日电百奥赛图-B 发布自愿公告，宣布IDEAYA Biosciences, Inc.已行使选项，获得公司B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性抗体偶联药物IDE034的全球独家授权，并提名该项目为开发候选药物。根据双方协议，公司将获得总额达4.1亿美元的各项费用，其中包括最多1亿美元的临床开发和监管里程碑付款。IDE034预计在2025年向美国FDA提交新药临床试验申请，以支持首次人体试验的启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111193253abb5f487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111193253abb5f487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2482209244","title":"百奥赛图-B(02315)：IDEAYA提名具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性ADC(IDE034)作为开发候选药物并行使选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=2482209244","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482209244?lang=zh_cn&edition=full","pubTime":"2024-11-11 18:39","pubTimestamp":1731321563,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B 发布公告，IDEAYA Biosciences,Inc.，一家致力于发现和开发靶向治疗药物的肿瘤精准医疗公司，已行使选择权，获得百奥赛图具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性抗体偶联药物BCG034的全球独家授权，并提名该项目为开发候选药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","ADC","BK1161","02315","BK4080"],"gpt_icon":0},{"id":"2481994319","title":"百奥赛图-B盘中异动 早盘快速拉升14.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481994319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481994319?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:30","pubTimestamp":1730943006,"startTime":"0","endTime":"0","summary":"2024年11月07日早盘09时30分，百奥赛图-B股票出现异动，股价急速拉升14.75%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，百奥赛图-B、科济药业-B、巨子生物涨幅较大，振幅较大的相关个股有巨子生物、药明巨诺-B、泰格医药，振幅分别为4.39%、2.17%、1.53%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110709300698e41044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110709300698e41044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2480268793","title":"新药研发回暖？动物实验公司几家欢喜几家愁︱财报点评","url":"https://stock-news.laohu8.com/highlight/detail?id=2480268793","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480268793?lang=zh_cn&edition=full","pubTime":"2024-11-04 14:12","pubTimestamp":1730700764,"startTime":"0","endTime":"0","summary":"动物实验是新药研发中的重要一环，随着全球医药产业的快速发展，围绕动物实验环节也陆续衍生出了包括动物模型供应商、动物实验服务供应商等诸多企业。随着全球医药行业投融资环境趋于改善，身处产业链前端的国内动物实验相关企业是否已感知到需求的复苏？日前，药康生物（688046.SH）、南模生物（688265.SH）、昭衍新药（6...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OJcMymAHSDjPhtAQ5O7cAV8YUiJnXbMgwrqmglblA5yX4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OJcMymAHSDjPhtAQ5O7cAV8YUiJnXbMgwrqmglblA5yX4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241104A04OSE00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241104A04OSE00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["06127","02315","BK1141","BK1576","BK1161"],"gpt_icon":0},{"id":"2480009725","title":"维科(香港)经贸增持百奥赛图(02315)100万股 每股作价5.85港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480009725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480009725?lang=zh_cn&edition=full","pubTime":"2024-11-01 19:17","pubTimestamp":1730459822,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，10月31日，维科(香港)经贸有限公司增持百奥赛图(02315)100万股，平均每股作价为5.85港元，总金额为585万港元。增持后最新持股数目约为810.26万股，最新持股比例为7.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2480201661","title":"百奥赛图－Ｂ(02315)出现大手卖出100万股，成交价$5.85，涉资585万","url":"https://stock-news.laohu8.com/highlight/detail?id=2480201661","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480201661?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:01","pubTimestamp":1730422860,"startTime":"0","endTime":"0","summary":"[大手成交]百奥赛图－Ｂ(02315)在上午09:01出现大手卖出，成交量为100万，成交价为港币$5.85，涉资585万。至目前为止，股价无升跌，今日最高价为$5.85，而最低价为$5.85，总成交量为100万股，总成交金额港币$585万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2411011/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2479211634","title":"百奥赛图-B盘中异动 临近午盘急速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479211634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479211634?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:47","pubTimestamp":1730260040,"startTime":"0","endTime":"0","summary":"2024年10月30日临近午盘11时47分，百奥赛图-B股票出现异动，股价大幅下挫5.31%。截至发稿，该股报6.060港元/股，成交量5.15万股，换手率0.05%，振幅5.94%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。百奥赛图-B股票所在的生物技术行业中，整体跌幅为1.93%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030114720971a31e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030114720971a31e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2479651440","title":"百奥赛图-B盘中异动 下午盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479651440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479651440?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:19","pubTimestamp":1730186345,"startTime":"0","endTime":"0","summary":"2024年10月29日下午盘15时19分，百奥赛图-B股票出现异动，股价急速下挫5.01%。截至发稿，该股报6.440港元/股，成交量11.3万股，换手率0.10%，振幅4.72%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.26%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029151905ab7de2ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029151905ab7de2ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2477352489","title":"百奥赛图-B(02315)下跌6.78%，报6.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352489","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352489?lang=zh_cn&edition=full","pubTime":"2024-10-24 13:52","pubTimestamp":1729749140,"startTime":"0","endTime":"0","summary":"10月24日，百奥赛图-B(02315)盘中下跌6.78%，截至13:52，报6.6元/股，成交109.31万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/24135244379982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2477510396","title":"百奥赛图-B盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477510396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477510396?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:48","pubTimestamp":1729734515,"startTime":"0","endTime":"0","summary":"2024年10月24日早盘09时48分，百奥赛图-B股票出现异动，股价大幅跳水5.23%。截至发稿，该股报6.710港元/股，成交量5.15万股，换手率0.05%，振幅5.65%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.31%。百奥赛图-B公司简介：北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024094835971a1e93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024094835971a1e93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2477806170","title":"百奥赛图-B(02315)下跌5.34%，报7.09元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477806170","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477806170?lang=zh_cn&edition=full","pubTime":"2024-10-22 15:38","pubTimestamp":1729582712,"startTime":"0","endTime":"0","summary":"10月22日，百奥赛图-B(02315)盘中下跌5.34%，截至15:38，报7.09元/股，成交101.39万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/22153844281640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02315","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.1437},{"period":"3month","weight":-0.062},{"period":"6month","weight":-0.3234},{"period":"1year","weight":-0.5272},{"period":"ytd","weight":-0.5075}],"compareEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":-0.0695},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.051},{"period":"1year","weight":0.0932},{"period":"ytd","weight":0.1239}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要从事药物开发业务及临床前研究的公司。该公司通过五个分部开展业务。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动物。抗体开发分部利用抗体发现平台识别有可能成为候选药物的抗体。创新药开发分部研发创新药，专注肿瘤学和自身免疫性疾病治疗。","exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}